Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial

Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial

Item

http://www.wikidata.org/entity/Q28297711

Q28297711

about

Ongoing challenges in the management of malaria The clinical efficacy of artemether/lumefantrine (Coartem)Paediatric Formulations of Artemisinin-Combination Therapies for Treating Uncomplicated Malaria in Children Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria The rise of multiple imputation: a review of the reporting and implementation of the method in medical research Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia Experience of safety monitoring in the context of a prospective observational study of artemether-lumefantrine in rural Tanzania: lessons learned for pharmacovigilance reporting.Sustainable development of a GCP-compliant clinical trials platform in Africa: the malaria clinical trials alliance perspective.Identification of Cryptosporidium parvum active chemical series by Repurposing the open access malaria box Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials.Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis.Update on the efficacy, effectiveness and safety of artemether-lumefantrine combination therapy for treatment of uncomplicated malaria.Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?Neuroauditory toxicity of artemisinin combination therapies-have safety concerns been addressed?Tolerability and efficacy of a pediatric granule formulation of artesunate-mefloquine in young children from Cameroon with uncomplicated falciparum malaria A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in children: a multisite, open-label, two-cohort, clinical trial in Mozambique Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects Artemether-lumefantrine: an option for malaria.Changing malaria intervention coverage, transmission and hospitalization in Kenya.Malaria: an update on current chemotherapy.Health & demographic surveillance system profile: The Kombewa health and demographic surveillance system (Kombewa HDSS).Drug-Resistant Malaria: The Era of ACT.Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia Early variations in plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: implications on delayed parasite clearance.Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis.Pharmacokinetic and pharmacodynamic characteristics of a new pediatric formulation of artemether-lumefantrine in African children with uncomplicated Plasmodium falciparum malaria Product Development Partnerships: Case studies of a new mechanism for health technology innovation Population pharmacokinetics of artemether, lumefantrine, and their respective metabolites in Papua New Guinean children with uncomplicated malaria.Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®).The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data.Artemether-Lumefantrine Combination Therapy for Treatment of Uncomplicated Malaria: The Potential for Complex Interactions with Antiretroviral Drugs in HIV-Infected Individuals.The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel.Similar efficacy and safety of artemether-lumefantrine (Coartem®) in African infants and children with uncomplicated falciparum malaria across different body weight ranges Intravenous pharmacokinetics, oral bioavailability, dose proportionality and in situ permeability of anti-malarial lumefantrine in rats.Tailoring a Pediatric Formulation of Artemether-Lumefantrine for Treatment of Plasmodium falciparum Malaria.Surveillance for the safety and effectiveness of artemether-lumefantrine in patients with uncomplicated Plasmodium falciparum malaria in the USA: a descriptive analysis Lumefantrine and Desbutyl-Lumefantrine Population Pharmacokinetic-Pharmacodynamic Relationships in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria on the Thailand-Myanmar Border.Repeated artemisinin-based combination therapies in a malaria hyperendemic area of Mali: efficacy, safety, and public health impact An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia

P2860

Q17485687-5C8D6A3F-093B-4094-8094-D20F753FE50E Q21034141-6D0F6612-5B54-419C-9FCC-446B708769F1 Q24203930-B4E0FF09-A487-4509-BF7E-FDBB4BD9FF53 Q24614989-578B22A0-9760-46DB-963F-255CB7050D70 Q26828889-22B48698-56D3-4705-93FF-96837E462C83 Q27497242-CD1F7FFA-5EB5-4747-B517-7D932E863C85 Q30396779-DA2C71F4-F530-4E60-8304-6DFAAC18A053 Q30396940-BDC769C7-9AD2-414F-8282-9CC92BD02A81 Q30486772-AB8FB264-068C-4EA7-8233-169ADD787DB6 Q30592761-7D7C7E5D-77CF-4B51-9971-5A38CB23AD46 Q30995133-F507C730-DAC0-4294-A7C4-F1F4621256B5 Q33635019-CAD1CE3B-F2F8-4773-BA0B-71CD87E92F10 Q33670134-D6C29501-26E5-4146-A89F-B443312E41EB Q33841142-8EB1BD00-F73A-4515-BC1D-AC896D300C29 Q33880614-3074CFF8-57BF-401E-BC22-11A431C08F88 Q34020818-460FD806-B426-46E2-8B20-3FDFF5EC15CD Q34042533-4D959D41-AA16-4859-B169-EA7B8291556F Q34154423-39BAAC91-95DA-4E78-B45C-666BB0FB8BC8 Q34267667-8FC4CF56-F565-4440-BCE9-020C29A77F11 Q34273825-7DEF382B-39C8-40F4-A38B-CF3E3F439348 Q34433106-BD220C24-0FB4-467A-9948-7A90A34FEE7B Q34649350-6707BBD0-99AB-4FCD-8DC1-36FCBB8DD5D3 Q34681141-3CC46FAB-1845-47FD-92D5-5009FBCC0FA8 Q35031434-B1C71BC8-25DC-40E5-9C22-B44DEE0B02BB Q35154559-EB07B7A3-9198-46EB-A2E8-D6DB20C5CB07 Q35179184-AF4BB8AB-0CEC-4C62-AC72-8F6A88C2C856 Q35191375-82363A1F-B9C2-4F80-AB3E-CF47E1CB79BF Q35219522-1F16360A-47F9-4BF6-951C-59679EF6FB7B Q35363704-8CA0C130-AA20-4B31-92CF-9A96ACD462C3 Q35530639-AD0490B2-3F68-41F3-925B-F076BD416ABD Q35580908-82F9B616-A113-4385-8FDA-B05F1DF1FA0A Q35692270-78E6E237-8638-4E95-A820-0E5CD7EBB4B9 Q35761615-E38329BA-A6EE-4C0C-8D7C-E4332DE6F46F Q35834482-7F9DEDC4-BEDE-44CA-A218-54776C387591 Q35834996-4BB1F1FE-6FE4-477F-8EAC-900946491EE1 Q35860066-5E0B8BD3-EE51-43D8-AC12-3245D2864AE2 Q36069930-0B6F7B2A-F64D-419A-BE92-CF3D5999E785 Q36075976-7B45AB91-17EE-4013-8BF0-85E0A57FDFD9 Q36080127-4EA200A8-27D5-4E96-A171-CA7AEDAE2A63 Q36175374-722EE8C5-1E67-45B2-9442-74F50A88960E

P2860

Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial

Item

http://www.wikidata.org/entity/Q28297711

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu